OpenAlex
PricingAboutJobs
Log inGet started
Work

Efficacy and safety of an intensified schedule of tremelimumab for chemotherapy-resistant malignant mesothelioma: an open-label, single-arm, phase 2 study

HTML

Year: 2015
Type: article
Study design: Clinical Trial
Source: The Lancet Respiratory Medicine
DOI: 10.1016/s2213-2600(15)00092-2
Authors: Luana Calabrò, Aldo Morra, Ester Fonsatti, Ornella Cutaia, Carolina Fazio, Diego Annesi, Marica Lenoci, Giovanni Amato, Riccardo Danielli, Maresa Altomonte, Diana Giannarelli, Anna Maria Di Giacomo, Michele Maio
Institutions: University of Siena, Azienda Ospedaliera Universitaria Senese, Instituto Nazionale Tumori Regina Elena
Language: English

Topic: Occupational and environmental lung diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: malignant mesothelioma, tremelimumab, CTLA-4 blockade, immune checkpoint inhibitors, immune-related adverse events, treatment safety, exposure-response analysis, peritoneal mesothelioma, epithelioid mesothelioma, sarcomatoid mesothelioma
SDG: Good health and well-being

Open Access status: closed

Funder: European Commission
OpenAlex ID: W2057312839
FWCI: 22.4
Cites: 26
Cited by: 217
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms